Abstract
Although cardiac resynchronization therapy (CRT) has become well established in the treatment of heart failure, the management of patients who do not respond after CRT remains a key challenge. This review will summarize what we have learned about non-responders over the last 20years and discuss methods for optimizing response, including the introduction of novel therapies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have